Khalid Ibrahim, D., and N. Akram Yahya. “Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus As a DYRK1A Inhibitor”. Iraqi Journal of Pharmacy, vol. 20, no. 2, Dec. 2023, pp. 168-73, doi:10.33899/iphr.2023.141712.1048.